InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Detke Michael J., Directeur Médical. Insider active across 1 company, notably Cortexyme, Inc.. Cumulatively, 5 disclosures have been published. History available since 6 July 2021. The latest transaction was filed on 3 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
140,000 shares0Common StockSEC:0001209191-22-016428:0
10,000 shares@ US$2.2322.2% of flowCommon StockSEC:0001209191-21-051214:0
10,000 shares@ US$2.2322.2% of flowCommon StockSEC:0001209191-21-051214
12,600 shares@ US$2.2327.8% of flowCommon StockSEC:0001209191-21-045948
12,600 shares@ US$2.2327.8% of flowCommon StockSEC:0001209191-21-045948:0
5 of 5 declarations
About Detke Michael J.
Michael J. Detke is the Chief Medical Officer at Cortexyme, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives. Detke brings valuable expertise in drug research and development, contributing to innovation in healthcare. His commitment to improving patient care is essential in guiding Cortexyme's projects. He collaborates with research teams to ensure the success of clinical trials and the development of new treatments.
